Nabumetone
- Product NDC
- 70934-432
- 11-digit product format
- 709340432
- Labeler code
- 70934
- Product ID
- 70934-432_ad27d381-cbf6-ef34-e053-2995a90ab32f
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Nabumetone
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Denton Pharma, Inc. DBA Northwind Pharmaceuticals
- Application
- ANDA091083
- Marketing category
- ANDA
- Marketing start
- 2019-08-22
- Marketing end
- 0000-00-00
- Substance
- NABUMETONE
- Active strength
- 750 mg/1
- Pharmacologic classes
- Cyclooxygenase Inhibitors [MoA],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70934-432-30 | 70934043230 | 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (70934-432-30) | 2019-08-22 | 0000-00-00 | No | No | Current |
| 70934-432-60 | 70934043260 | 60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (70934-432-60) | 2020-02-26 | 0000-00-00 | No | No | Current |